Effect of Iron Accumulation on Bone Mineral Density in Patients Diagnosed With Transfusion-Dependent Thalassemia

Effect of Iron Accumulation on Bone Mineral Density in Patients Diagnosed With Transfusion-Dependent Thalassemia

Conclusion: Our investigation has demonstrated that in patients with TDT, elevated transferrin saturation may be a sign of osteoporosis.

Saved in:

Bibliographic Details
Main Authors:	Cem Selim, Rafiye Çiftçiler, Ayşe Hilal Eroğlu Küçükdiler, Fatma Keklik Karadağ, Nur Soyer
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	International Journal of Clinical Practice
Online Access:	http://dx.doi.org/10.1155/ijcp/5411059
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA
by: Kun Yang, et al.
Published: (2024-01-01)

Relationship between response to first-line steroid treatment in adult immune thrombocytopenic purpura and the course of the disease
by: Esra Seçkin, et al.
Published: (2024-11-01)

THE RELATION BETWEEN TYPES OF IRON CHELATORS AND FERITIN ON OSTEOCALCIN OF THALASSEMIA PATIENTS WITH REPEATED TRANSFUSIONS
by: Sesa Amelia, et al.
Published: (2020-01-01)

Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia
by: Tubagus Djumhana Atmakusuma, et al.
Published: (2021-01-01)

Iron Overload and Serum and Saliva Ferritin Levels in Individuals with Beta Thalassemia Needing Several Blood Transfusions
by: Anaam Mahdi Hadi, et al.
Published: (2025-06-01)

Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia
by: Pustika Amalia Wahidiyat, et al.
Published: (2018-10-01)

Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia
by: Pustika Amalia Wahidiyat, et al.
Published: (2018-10-01)

Correlation of Serum Ferritin and Cardiac Iron Toxicity with Cardiac Function in Transfusion Dependent Beta-Thalassemia Major Patients
by: Tubagus Djumhana Atmakusuma, et al.
Published: (2021-10-01)

Investigating the Effect of Iron Chelation Therapy With Deferasirox on Liver Aminotransferases Levels in Transfusion-dependent β-thalassemia Patients
by: Shayan Pourkazem, et al.
Published: (2024-06-01)

Transfusion frequency, ferritin, and carotid intima media thickness in transfusion-dependent thalassemia patients
by: Rahmat Cahyanur, et al.
Published: (2025-04-01)

MOLECULAR ANALYSIS OF NON-TRANSFUSION DEPENDENT THALASSEMIA ASSOCIATED WITH HEMOGLOBIN E-β-THALASSEMIA DISEASE WITHOUT α--THALASSEMIA
by: Paramee Phanrahan, et al.
Published: (2019-06-01)

Blood Lead and Cadmium Levels in Transfusion-Dependent Thalassemia Patients
by: Balqees Kadhim Hasan, et al.
Published: (2025-04-01)

Hepatic iron overload in transfusion-dependent paediatric thalassemia (TDT) patients: association of magnetic resonance imaging with serum ferritin level
by: Anita Mehta, et al.
Published: (2025-07-01)

Comparison of Efficacy, Safety, and Humanistic Outcomes of Iron-Chelation Therapy in Pediatrics Suffering from Transfusion-Dependent β-Thalassemia Major
by: Narayana Goruntla, et al.
Published: (2020-07-01)

Impact of Hemoglobin, Leucocyte and Thrombocyte Levels at Diagnosis on the Survival Outcomes of Chronic Myeloid Leukemia Patients
by: Taha Ulutan Kars, et al.
Published: (2024-02-01)

Lipid Profile Abnormalities in ß-Thalassemia Patients with Multiple Blood Transfusions
by: Syeda Sabahat Haidar, et al.
Published: (2023-10-01)

Prevalence of osteoporosis & osteopenia in transfusion-dependent thalassemia in Sulaimaniyah city, Iraq
by: Hunar Gharib Mahmood, et al.
Published: (2024-06-01)

Proportion of Hypogonadism in Transfusion-Dependent Thalassemia Patients and Its Contributing Factors
by: Dian Anindita Lubis, et al.
Published: (2024-04-01)

IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES
by: Paolo Cianciulli
Published: (2009-06-01)

Thalassemia and assisted reproduction: non-transfusion-dependent thalassemia shows no significant effect on live birth rates after embryo transfer
by: Li Fan, et al.
Published: (2025-03-01)

Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent β-Thalassemia: A Single Thalassemia Center Cohort Study
by: Kiran Kanwal, et al.
Published: (2025-07-01)

Luspatercept versus mitapivat for non‐transfusion‐dependent β‐thalassemia: Dare to compare?
by: Khaled M. Musallam, et al.
Published: (2025-07-01)

Relationship between Serum Ferritin Levels and Sarcopenia in Transfusion-Dependent Thalassemia Patient
by: Rendra Prasetya Saefudin, et al.
Published: (2024-12-01)

IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE
by: Raffaella Mariani, et al.
Published: (2009-10-01)

Risk factors of low bone mass in young patients with transfusion-dependent beta-thalassemia
by: Wei Zhang, et al.
Published: (2025-07-01)

Folate supplementation in transfusion-dependent thalassemia: Do we really need such high doses?
by: Gaurav Tripathi, et al.
Published: (2016-01-01)

The frequency of clinical and subclinical hypothyroidism in transfusion dependent thalassemia patients in Slemani city /Iraq
by: Dezheen Jamal Mohammed Rashid, et al.
Published: (2024-06-01)

SALIVA IRON AND FERRITIN LEVELS IN PATIENTS WITH THALASSEMIA AND IRON DEFICIENCY ANEMIA
by: Duran Canatan, et al.
Published: (2012-01-01)

Servo prevalence of hepatitis B and C and HIV in multiple transfusions ß-thalassemia: Result from an only thalassemia day care unit in Kerman-Iran
by: Amir-Hooshang Sheikh-Bardsiri, et al.
Published: (2014-08-01)

ASSOCIATION BETWEEN 25-HYDROXYVITAMIN D LEVELS AND GROWTH PARAMETERS IN THALASSEMIA WITH REPEATED BLOOD TRANSFUSION
by: Najma Khairani Harahap, et al.
Published: (2020-11-01)

Does splenectomy influence the development of Hypothyroidism in Transfusion Dependent Thalassemia Patients? A retrospective study.
by: Christos KATTAMIS, et al.
Published: (2019-10-01)

Dysregulation of Ceruloplasmin, α2-Macroglobulin, and Alpha-2-HS-Glycoprotein in Transfusion-Dependent Thalassemia
by: Afshan Sumera, et al.
Published: (2025-01-01)

SUCCESSFUL REDUCTION OF TRANSFUSION DEPENDENCE WITH LUSPATERCEPT IN A PATIENT WITH THALASSEMIA MAJOR: A CASE REPORT
by: Gökhan Demirci, et al.
Published: (2024-12-01)

Study of platelet activation, hypercoagulable state, and pulmonary hypertension in patients with transfusion-dependent beta-thalassemia
by: Lanja Othman Haji, et al.
Published: (2024-12-01)

Red blood cell alloimmunization among transfusion-dependent thalassemia major patients in Northeastern Iran
by: Leila Mobasheri, et al.
Published: (2024-12-01)

High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles
by: Jitlada Chinsuwan, et al.
Published: (2020-10-01)

Therapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload
by: adel abd elhaleim hagag
Published: (2014-08-01)

A Rare Case of High Physical Endurance in Transfusion-Dependent Thalassemia Patients with Poor Cardiac Functions
by: Nathasha Brigitta Selene, et al.
Published: (2025-06-01)

Association of Hepatic Fibrosis Measured by Transient Elastography with Ferritin Level of Patients with Transfusion Dependent Thalassemia in Iraq
by: zainab Gataa, et al.
Published: (2025-06-01)

Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia
by: Anuraag R. Kansal, et al.
Published: (2021-01-01)